Impact of non-uniform attenuation correction in a dynamic [18F]-FDOPA brain PET/MRI study

被引:6
|
作者
Cabello, Jorge [1 ,7 ]
Avram, Mihai [1 ,2 ,3 ]
Brandl, Felix [2 ,3 ]
Mustafa, Mona [1 ]
Scherr, Martin [4 ,5 ]
Leucht, Claudia [4 ]
Leucht, Stefan [4 ]
Sorg, Christian [2 ,3 ,4 ]
Ziegler, Sibylle I. [1 ,6 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Neuroradiol, Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Neuroimaging Ctr TUM NIC, Munich, Germany
[4] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat, Munich, Germany
[5] Paracelsus Med Univ, Univ Klin Psychiat & Psychotherapie, Salzburg, Austria
[6] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Klin & Poliklin Nuk M3d, Munich, Germany
[7] Siemens Healthineers Mol Imaging, Knoxville, TN USA
关键词
PET/MRI; MR-based attenuation correction; F-18]-FDOPA-PET; Patlak; Simplified reference tissue model; PET; DOPAMINE; MODEL; SCHIZOPHRENIA; COEFFICIENTS; ATLAS; BONE; MRI;
D O I
10.1186/s13550-019-0547-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background PET (positron emission tomography) biokinetic modelling relies on accurate quantitative data. One of the main corrections required in PET imaging to obtain high quantitative accuracy is tissue attenuation correction (AC). Incorrect non-uniform PET-AC may result in local bias in the emission images, and thus in relative activity distributions and time activity curves for different regions. MRI (magnetic resonance imaging)-based AC is an active area of research in PET/MRI neuroimaging, where several groups developed in the last few years different methods to calculate accurate attenuation (mu-)maps. Some AC methods have been evaluated for different PET radioisotopes and pathologies. However, AC in PET/MRI has scantly been investigated in dynamic PET studies where the aim is to get quantitative kinetic parameters, rather than semi-quantitative parameters from static PET studies. In this work, we investigated the impact of AC accuracy in PET image absolute quantification and, more importantly, in the slope of the Patlak analysis based on the simplified reference tissue model, from a dynamic [F-18]-fluorodopa (FDOPA) PET/MRI study. In the study, we considered the two AC methods provided by the vendor and an in-house AC method based on the dual ultrashort time echo MRI sequence, using as reference a multi-atlas-based AC method based on a T1-weighted MRI sequence. Results Non-uniform bias in absolute PET quantification across the brain, from - 20% near the skull to - 10% in the central region, was observed using the two vendor's mu-maps. The AC method developed in-house showed a - 5% and 1% bias, respectively. Our study resulted in a 5-9% overestimation of the PET kinetic parameters with the vendor-provided mu-maps, while our in-house-developed AC method showed < 2% overestimation compared to the atlas-based AC method, using the cerebellar cortex as reference region. The overestimation obtained using the occipital pole as reference region resulted in a 7-10% with the vendor-provided mu-maps, while our in-house-developed AC method showed < 6% overestimation. Conclusions PET kinetic analyses based on a reference region are especially sensitive to the non-uniform bias in PET quantification from AC inaccuracies in brain PET/MRI. Depending on the position of the reference region and the bias with respect to the analysed region, kinetic analyses suffer different levels of bias. Considering bone in the mu-map can potentially result in larger errors, compared to the absence of bone, when non-uniformities in PET quantification are introduced.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Validation of PET/MRI attenuation correction methodology in the study of brain tumours
    De Luca, Francesca
    Bolin, Martin
    Blomqvist, Lennart
    Wassberg, Cecilia
    Martin, Heather
    Delgado, Anna Falk
    BMC MEDICAL IMAGING, 2020, 20 (01)
  • [42] Acute and Sustained Effects of Methylphenidate on Cognition and Presynaptic Dopamine Metabolism: An [18F]FDOPA PET Study
    Schabram, Ina
    Henkel, Karsten
    Shali, Siamak Mohammadkhani
    Dietrich, Claudia
    Schmaljohann, Joern
    Winz, Oliver
    Prinz, Susanne
    Rademacher, Lena
    Neumaier, Bernd
    Felzen, Marc
    Kumakura, Yoshitaka
    Cumming, Paul
    Mottaghy, Felix M.
    Gruender, Gerhard
    Vernaleken, Ingo
    JOURNAL OF NEUROSCIENCE, 2014, 34 (44): : 14769 - 14776
  • [43] Is there a need for premedication with Carbidopa for static and dynamic 18F-FDOPA PET imaging of brain tumors?
    Bros, M.
    Zaragori, T.
    Rech, F.
    Blonski, M.
    Taillandier, L.
    Verger, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S184 - S184
  • [44] PET imaging study of [18F]-FDOPA uptake in first-degree relatives of schizophrenic patients
    Huttunen, J
    Heinimaa, M
    Ilonen, T
    Suomela, T
    Korkeila, J
    Ristkari, T
    Plathin, M
    Syvälahti, E
    McGlashan, T
    Salokangas, RKR
    Hietala, J
    NORDIC JOURNAL OF PSYCHIATRY, 2001, 55 (02) : 94 - 94
  • [45] [18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease
    Pavese, N.
    Simpson, B. S.
    Metta, V.
    Ramlackhansingh, A.
    Chaudhuri, K. Ray
    Brooks, D. J.
    NEUROIMAGE, 2012, 59 (02) : 1080 - 1084
  • [46] Clinical Impact of MR-based Attenuation Correction in Dementia Evaluation with 18F-FDG PET/MRI
    Oen, S. K.
    Karlberg, A.
    Keil, T.
    Eikenes, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S392 - S393
  • [47] 18F-FDOPA PET imaging of brain tumors:: Comparison study with 18F-FDG PET and evaluation of diagnostic accuracy
    Chen, Wei
    Silverman, Daniel H. S.
    Delaloye, Sibylle
    Czernin, Johannes
    Kamdar, Nirav
    Pope, Whitney
    Satyamurthy, Nagichettiar
    Schiepers, Christiaan
    Cloughesy, Tirnothy
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (06) : 904 - 911
  • [48] F-18-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors
    Gauvain, Karen
    Ponisio, Maria Rosana
    Barone, Amy
    Grimaldi, Michael
    Parent, Ephraim
    Leeds, Hayden
    Goyal, Manu
    Rubin, Joshua
    McConathy, Jonathan
    NEURO-ONCOLOGY PRACTICE, 2018, 5 (01) : 28 - 36
  • [49] Occurrence of an Artifact in Brain F-18-FDG PET with Calculated Attenuation Correction
    von Borczyskowski, Daniel
    Schulte, Ulrike
    Brenner, Winfried
    Clausen, Malte
    Buchert, Ralph
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2006, 34 (04) : 232 - 234
  • [50] DeepDixon synthetic CT for [18F]FET PET/MRI attenuation correction of post-surgery glioma patients with metal implants
    Ladefoged, Claes Nohr
    Andersen, Flemming Littrup
    Andersen, Thomas Lund
    Anderberg, Lasse
    Engkebolle, Christian
    Madsen, Karine
    Hojgaard, Liselotte
    Henriksen, Otto Molby
    Law, Ian
    FRONTIERS IN NEUROSCIENCE, 2023, 17